Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sapropterin Expanded Access Program

NCT00484991 is registered in ClinicalTrials.gov with BioMarin Pharmaceutical as lead sponsor.

NCT NCT00484991
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00484991 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sapropterin Expanded Access Program
Lead sponsor
BioMarin Pharmaceutical
Phase
Expanded access
Overall status
Approved for marketing
Start date
Not reported
Completion date
Not reported
Enrollment
Not reported
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

phenylketonuria